My Quote Request
No products added yet
6505-01-317-1121
20 Products
NDC00524-0208-05
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505013171121
NSN
6505-01-317-1121
NDC00524-0208-05
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505013171121
NSN
6505-01-317-1121
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 333.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERYTHROMYCIN TABLETS USP 333MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOOTS PHARMACEUTICALS INC.
Related Searches:
NDC00074-6320-53
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505013171121
NSN
6505-01-317-1121
NDC00074-6320-53
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505013171121
NSN
6505-01-317-1121
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 333.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ERYTHROMYCIN TABLETS USP 333MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOOTS PHARMACEUTICALS INC.
Related Searches:
BETAGAN
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
BETAGAN
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: SPECIAL ADMINISTRATION CAP WHICH IS DESIGNED FOR TWICE DAILY DOSING
Related Searches:
BETAGAN C CAP
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
BETAGAN C CAP
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: SPECIAL ADMINISTRATION CAP WHICH IS DESIGNED FOR TWICE DAILY DOSING
Related Searches:
NDC00023-4385-15
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
NDC00023-4385-15
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: SPECIAL ADMINISTRATION CAP WHICH IS DESIGNED FOR TWICE DAILY DOSING
Related Searches:
NDC11980-0252-21
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
NDC11980-0252-21
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: SPECIAL ADMINISTRATION CAP WHICH IS DESIGNED FOR TWICE DAILY DOSING
Related Searches:
NDC24208-0505-15
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
NDC24208-0505-15
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
MFG
BAUSCH & LOMB PHARMACEUTICALS DIV BAUSCH & LOMB PHAMACEUTICAL
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: SPECIAL ADMINISTRATION CAP WHICH IS DESIGNED FOR TWICE DAILY DOSING
Related Searches:
NDC60758-0060-15
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
NDC60758-0060-15
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
MFG
PACIFIC PHARMA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: SPECIAL ADMINISTRATION CAP WHICH IS DESIGNED FOR TWICE DAILY DOSING
Related Searches:
NDC61314-0229-15
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
NDC61314-0229-15
LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505013171128
NSN
6505-01-317-1128
MFG
FALCON PHARMACEUTICALS LTD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V LEVOBUNOLOL HYDROCHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: SPECIAL ADMINISTRATION CAP WHICH IS DESIGNED FOR TWICE DAILY DOSING
Related Searches:
2B3520
CEFOPERAZONE SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505013171638
NSN
6505-01-317-1638
2B3520
CEFOPERAZONE SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505013171638
NSN
6505-01-317-1638
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEPOPERAZONE EQUIVALENT
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOPERAZONE SODIUM IN DEXTROSE INJECTION 50ML BAG 24S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: PREMIXED IN AN ISO-OSMOTIC SOLUTION W/APPROXIMATELY 2.3 GRAMS DEXTROSE HYDROUS,USP; FROZEN; SINGLE DOSE; BAG W/AT LEAST ONE PERMANENTLY ATTACHED OUTLET PORT; FOR USE W/STOCKLISTED INTRAVENOUS SETS
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
CEFOBID
CEFOPERAZONE SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505013171638
NSN
6505-01-317-1638
CEFOBID
CEFOPERAZONE SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505013171638
NSN
6505-01-317-1638
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEPOPERAZONE EQUIVALENT
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOPERAZONE SODIUM IN DEXTROSE INJECTION 50ML BAG 24S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: PREMIXED IN AN ISO-OSMOTIC SOLUTION W/APPROXIMATELY 2.3 GRAMS DEXTROSE HYDROUS,USP; FROZEN; SINGLE DOSE; BAG W/AT LEAST ONE PERMANENTLY ATTACHED OUTLET PORT; FOR USE W/STOCKLISTED INTRAVENOUS SETS
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00049-1216-18
CEFOPERAZONE SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505013171638
NSN
6505-01-317-1638
NDC00049-1216-18
CEFOPERAZONE SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505013171638
NSN
6505-01-317-1638
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEPOPERAZONE EQUIVALENT
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFOPERAZONE SODIUM IN DEXTROSE INJECTION 50ML BAG 24S
III PROTECTIVE STORAGE FEATURE: FROZEN FOR PRESERVATION
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: PREMIXED IN AN ISO-OSMOTIC SOLUTION W/APPROXIMATELY 2.3 GRAMS DEXTROSE HYDROUS,USP; FROZEN; SINGLE DOSE; BAG W/AT LEAST ONE PERMANENTLY ATTACHED OUTLET PORT; FOR USE W/STOCKLISTED INTRAVENOUS SETS
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
2A6222
AMINO ACID INJECTION
NSN, MFG P/N
6505013171641
NSN
6505-01-317-1641
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 250ML BT 12S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.0 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00338-0471-02
AMINO ACID INJECTION
NSN, MFG P/N
6505013171641
NSN
6505-01-317-1641
NDC00338-0471-02
AMINO ACID INJECTION
NSN, MFG P/N
6505013171641
NSN
6505-01-317-1641
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 250ML BT 12S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.0 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
RENAMIN 6.5%
AMINO ACID INJECTION
NSN, MFG P/N
6505013171641
NSN
6505-01-317-1641
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACIDS INJECTION WITH ELECTROLYTES 250ML BT 12S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.0 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
16933
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505013172030
NSN
6505-01-317-2030
16933
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505013172030
NSN
6505-01-317-2030
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SCORED
Related Searches:
NDC00182-1158-10
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505013172030
NSN
6505-01-317-2030
NDC00182-1158-10
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505013172030
NSN
6505-01-317-2030
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SCORED
Related Searches:
NDC49884-0544-01
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505013172031
NSN
6505-01-317-2031
NDC49884-0544-01
RANITIDINE TABLETS,USP
NSN, MFG P/N
6505013172031
NSN
6505-01-317-2031
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS RANITIDINE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE HYDROCHLORIDE TABLETS 150MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
2B0064
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013173336
NSN
6505-01-317-3336
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
7922-09-39
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013173336
NSN
6505-01-317-3336
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
